Related Experiment Video
Updated: Mar 29, 2026
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
37.6K
[Vitamin E and Alzheimer's Disease].
Moeko Shinohara1, Masahito Yamada
1Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|December 1, 2015
Summary
Vitamin E may slow functional decline in Alzheimer's disease patients. However, it showed no cognitive benefits for mild cognitive impairment or healthy older adults, requiring further research for therapeutic use.
Area of Science:
- Neuroscience
- Nutritional Science
- Gerontology
Background:
- Oxidative stress is implicated in Alzheimer's disease (AD) pathogenesis.
- Epidemiological studies suggest a link between high dietary vitamin E intake and reduced AD incidence.
- Vitamin E is a powerful antioxidant with potential neuroprotective properties.
Purpose of the Study:
- To evaluate the efficacy of vitamin E in Alzheimer's disease treatment and prevention.
- To determine if vitamin E can delay functional decline in AD patients.
- To assess the cognitive benefits of vitamin E in various populations.
Main Methods:
- Review of epidemiological studies on vitamin E intake and AD incidence.
- Analysis of randomized controlled trials (RCTs) investigating vitamin E treatment in AD patients.
- Examination of RCTs assessing vitamin E in mild cognitive impairment (MCI) and healthy older adults.
Main Results:
- RCTs indicated that vitamin E treatment could delay functional decline in mild to moderate Alzheimer's disease.
- Vitamin E supplementation did not demonstrate cognitive benefits in patients with mild cognitive impairment.
- No cognitive advantages were observed in generally healthy older women receiving vitamin E.
Conclusions:
- Vitamin E may offer therapeutic benefits for functional decline in established Alzheimer's disease.
- Current evidence does not support the use of vitamin E for cognitive enhancement in MCI or healthy individuals.
- Further rigorous clinical trials are essential to confirm vitamin E's role as a therapeutic or preventive agent for Alzheimer's disease.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.6K
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.7K
Related Concept Videos
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:23Role of Neurotransmitters in Memory
2.9K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.9K
01:30Vitamins
3.0K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.0K
01:30Dementia
702
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
702
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
836
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
836